Resolution of inflammation: An organizing principle in biology and medicine.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing biological mechanisms and theoretical applications without original empirical data
PubMed 33915177 · doi:10.1016/j.pharmthera.2021.107879
What was done
This narrative review summarizes the biological concepts and historical framework surrounding the active resolution of inflammation. It reviews the role of essential polyunsaturated fatty acid-derived specialized pro-resolving mediators (SPMs)—including lipoxins, resolvins, protectins, and maresins—their receptors, efferocytosis mechanisms, and their proposed therapeutic potential in inflammatory conditions and cancer.
What was found
The abstract reports no numerical findings or quantitative metrics. It describes qualitative biological mechanisms: SPMs restrict neutrophil tissue infiltration, stimulate macrophage-mediated clearance of apoptotic neutrophils and debris, and counter-regulate pro-inflammatory eicosanoids and cytokines. It frames the failure of endogenous resolution pathways as a key driver of chronic inflammation and tumor-promoting host responses.
Why it matters
It outlines how active inflammation resolution mechanisms and specialized lipid mediators could serve as novel host-targeted therapeutic targets, particularly for mitigating chronic inflammatory diseases and tissue injury from standard cancer treatments.
Limits
The abstract describes a non-systematic narrative review lacking empirical trial data, primary human measurements, or quantitative effect sizes. Practical therapeutic efficacy, clinical dosing, safety, and translational validity in human patients cannot be assessed from this summary.
Cited by
- supports Charles Serhan at Harvard demonstrated that specialized pro-resolving mediators like resolvins and maresins derived from omega-3 fatty acids are critical for resolving inflammation.